Cronos Group Executive and Leadership Team

Guibison Henrique, the Chief Executive Officer at Cronos Group, directs the company's overarching strategic vision and operational execution. This leadership role involves guiding all business units to achieve global growth objectives and maintain market competitiveness. Henrique oversees the integration of international production and distribution networks, ensuring seamless operations across five continents. The Chief Executive Officer's responsibilities include fostering innovation within the cannabinoid sector and driving the company's expansion into new markets. By aligning departmental efforts with corporate goals, Henrique ensures Cronos Group maintains its position as a leading global cannabinoid company. This executive's focus remains on maximizing shareholder value through sustainable business practices and strategic market penetration. Guibison Henrique's leadership ensures the company's continued success in a dynamic industry.

Héctor Chacón Pérez, the Chief Executive Officer & Founder at Cronos Group, establishes the foundational principles and long-term direction for the organization. As a founder, Chacón Pérez brings deep insight into the company's origins and its evolution within the global cannabinoid market. This executive guides strategic initiatives aimed at expanding international production capabilities and distribution channels across diverse geographies. The Chief Executive Officer & Founder's role encompasses fostering a culture of innovation and ensuring the company's product offerings meet evolving consumer demands worldwide. Chacón Pérez oversees key partnerships and alliances that bolster Cronos Group's market presence. By championing the company's mission, Héctor Chacón Pérez drives forward the vision of global leadership in cannabinoid products. This executive's commitment ensures the company's sustained growth and impact.

Michael Gorenstein, the Chairman, President and Chief Executive Officer at Cronos Group, presides over the company's strategic governance and executive leadership. This multifaceted role involves setting the corporate agenda, overseeing board activities, and driving the overall business strategy. Gorenstein directs the company's expansion efforts, ensuring robust international production and distribution networks are effectively managed across five continents. The Chairman, President and Chief Executive Officer's responsibilities include fostering innovation within the cannabinoid industry and guiding the company's financial performance. Gorenstein ensures alignment between operational execution and long-term strategic objectives, reinforcing Cronos Group's global market position. This executive's leadership is critical for navigating the complexities of the international cannabinoid landscape and maximizing stakeholder value. Michael Gorenstein's tenure is marked by a commitment to sustainable growth and market leadership.

Anna Shlimak, the Chief Financial Officer at Cronos Group, manages the company's financial health and strategic fiscal planning. This executive oversees all financial operations, including accounting, treasury, and investor relations, ensuring robust fiscal management across international markets. Shlimak directs the allocation of capital to support global production and distribution expansion, aligning financial resources with strategic growth objectives. The Chief Financial Officer's responsibilities include developing financial models that support innovation in the cannabinoid sector and drive profitability. By ensuring compliance with global financial regulations, Anna Shlimak safeguards the company's assets and enhances its financial stability. This leadership position is crucial for maintaining investor confidence and supporting the company's ambitious market penetration strategies. Shlimak's expertise guides Cronos Group's financial trajectory.

Mike Kroslak, the Chief Operating Officer at Cronos Group, directs the company's day-to-day operational activities and ensures efficient execution of business strategies. This role involves overseeing the integration and optimization of international production facilities and distribution networks spanning five continents. Kroslak drives operational excellence, focusing on enhancing supply chain efficiency and product quality across all global markets. The Chief Operating Officer's responsibilities include implementing best practices in manufacturing and logistics to support the company's innovative product development in the cannabinoid industry. By managing operational risks and ensuring regulatory compliance, Mike Kroslak supports Cronos Group's sustained growth and market leadership. This executive's focus on operational effectiveness is key to achieving global business objectives and delivering value.

Dinor Levi, the Co-founder & Chief Operating Officer at Cronos Group, shapes the operational framework and strategic execution of the company's global initiatives. As a co-founder, Levi brings foundational knowledge and a long-term perspective to operational planning and development. This executive oversees the expansion and management of international production sites and distribution channels, ensuring seamless operations across diverse global markets. Levi drives efficiency improvements within the supply chain and manufacturing processes, supporting the company's commitment to innovation in the cannabinoid sector. The Co-founder & Chief Operating Officer's role includes fostering cross-functional collaboration to achieve strategic business outcomes. By ensuring operational integrity, Dinor Levi contributes significantly to Cronos Group's market position and sustained growth. This executive's leadership is vital for realizing the company's international vision.